Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

Hutchmed has continued to test sovleplenib in wAIHA in parallel, culminating in the delivery of data from a Chinese phase 3 ...

Phase 1 proof-of-concept study of CLY-124 in Sickle Cell Disease expected in Q4 2026 In vivo preclinical data assessing new compounds vs. standard of care in gold-standard, translatable myelofibrosis ...

A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding ...

Researchers have unveiled a way to flip genes back on without slicing into the genome, a shift that could make CRISPR far ...

A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and ...

A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia ...

CT scan of chest, abdomen, and pelvis shows high-disease burden, including multiple mediastinal and hilar nodes, deposits in ...

Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for ...

Abdullah, E.M. (2026) Intracranial Hypertension as an Initial Presentation of Polycythemia Vera: A Case Report. Open Journal ...

FDA oral Wegovy, solid fundamentals, and low P/E vs. Eli Lilly. Click for this updated look at NVO stock prospects as ...

As one of Nintendo's most iconic characters, Mario is everywhere on the Switch. The plumber has had multiple releases every year since the system first came out with no signs of stopping, even as we ...